AMORIM
 
Cork Stoppers
home | corticeira amorim | research & development | cork stoppers

CORK STOPPERS

In recent years Amorim & Irmãos, SGPS, S.A. has invested millions of dollars in research and development, with its main focus being on sensory and technical performance. The number one priority of the R&D department under the leadership of Prof. Miguel Cabral has been the defeat of TCA. More recently the focus has broadened to include oxygen ingress and the role of the closure in wine development.

The Cork Stoppers BU has continued to frame its activities within the following strategic orientations:

1. Resolving the TCA question

Amorim does not believe there is a single ‘magic wand’ solution to the problem of TCA. Rather, its strategy is to protect against TCA contamination at every stage of cork production and distribution. The company has instituted a range of preventive and curative measures across the production and distribution chain.

As part of its preventive strategy Amorim has introduced improvements at all stage of production, including:
new cork purchasing and selection procedures;

rigorous controls on storage and seasoning of raw corkwood;
a completely new boiling system for washing the corkwood, including the revolutionary CONVEX® system for trapping and removing volatile compounds such as TCA;
the INOS II process for washing the discs for Twin Top® and champagne corks.
In quality control, Amorim has upgraded sensory analysis with highly sophisticated instrumental analysis using gas chromatography (GC).

An article on Amorim’s quality control regime published in Australian and New Zealand Grapegrower and Winemaker is available (further reading link).

As a curative measure, it stands out the progresses registered in the ROSA®Evolution process, namely the excellent results obtained with the prototype. This evolution of the ROSA® system for application in natural cork stoppers not only makes it possible to improve the performance indicator, but above all it does not deform the natural cork stoppers and thus avoids the later correction phase. The importance of this process should be emphasised, because of its potential impact on winning market share, especially in the top wine segment. Given the good results obtained, the first industrial equipment will be installed in 2007.

Further information on Amorim’s anti-TCA strategy is contained in the presentations and transcripts of the ‘Latest Advances in Cork Processing Technology’ workshop at the 2004 Australian Wine Industry Technical Conference (http://www.corkfacts.com/presentn.htm).

2. Improving product performance

The development of a new glue for gluing discs has resulted from projects implemented to obtain new glues, under the strategic orientation “improving the performance of the product”. This will be put into effect in 2007 in one of the industrial units.

Research into new agglomeration glues has been stepped up, with the result that by the end of 2006 different solutions were being tested.

3. Increasing product knowledge

Concerning the “increase of knowledge of the product”, because of the impact it has had in the main markets, attention should be drawn to the publication of another article on the comparative permeability of synthetic stoppers, aluminium capsules and natural cork stoppers, where there are clear advantages in the use of cork stoppers:

 Non-destructive colorimetric method to determine the oxygen diffusion rate used in winemaking 

The year 2006 saw the beginning of far-reaching studies on the impact of the type of bottle (bottleneck) and the importance of the composition of the stopper, in the performance of champagne stoppers.

4. Optimising the production processes
In the strand “Optimising the production processes”, the project to develop new processes for boiling cork deserves a special mention. Given the good results obtained with the prototype, this project will continue.
5. Developing new types of cork stoppers
Conclusion of the second phase – identifying viable formulations – of a project developed in partnership with a research centre in the United Kingdom. This will continue in 2007 when tests are conducted on the formulations that have been developed.